열다한소탕가대황(熱多寒少湯加大黃) 복용 후 간 손상 수치가 상승된 1례

A Clinical Case of Liver Injury with Administration of Yeoldahanso-tang plus Rheum rhabarbarum

  • 권은미 (경희대학교 동서신의학병원 사상체질과) ;
  • 정의홍 (경희대학교 동서신의학병원 사상체질과) ;
  • 김은희 (경희대학교 동서신의학병원 사상체질과) ;
  • 서영광 (경희대학교 동서신의학병원 사상체질과) ;
  • 이수경 (경희대학교 동서신의학병원 사상체질과) ;
  • 김달래 (경희대학교 동서신의학병원 사상체질과) ;
  • 김선형 (경희대학교 동서신의학병원 사상체질과)
  • Kwon, Eun-Mi (Dept. of Sasang Constitutional Medicine, Kyunghee University East-West Neo Medical Center) ;
  • Jung, Yee-Hong (Dept. of Sasang Constitutional Medicine, Kyunghee University East-West Neo Medical Center) ;
  • Kim, Eun-Hee (Dept. of Sasang Constitutional Medicine, Kyunghee University East-West Neo Medical Center) ;
  • Seo, Young-Kwang (Dept. of Sasang Constitutional Medicine, Kyunghee University East-West Neo Medical Center) ;
  • Lee, Soo-Kyung (Dept. of Sasang Constitutional Medicine, Kyunghee University East-West Neo Medical Center) ;
  • Kim, Dal-Rae (Dept. of Sasang Constitutional Medicine, Kyunghee University East-West Neo Medical Center) ;
  • Kim, Sun-Hyung (Dept. of Sasang Constitutional Medicine, Kyunghee University East-West Neo Medical Center)
  • 투고 : 2009.06.20
  • 심사 : 2009.12.02
  • 발행 : 2009.12.31

초록

1. Objects: This case study reports a liver injury in treatment of constipation with Yeoldahanso-tang plus Rheum rhabarbarum. 2. Methods: The patient's subjective symptoms and the laboratory data including aspartate transaminase(AST), alanine transaminase(ALT), alkaline phosphatase(ALP), and gamma($\gamma$)-glutamyl transpeptidase(GGT) were observed before and after liver injury. We used the Roussel Uclaf Causality Assessment Method(RUCAM) scale in order to find out whether if Yeoldahanso-tang plus Rheum rhabarbarum was related with the liver injury. 3. Results: The patient's AST and ALT were elevated more than twice after a 3week administration period of herbal medicine. After discontinuation of the herbal medicine and administration of hepatic protective medication, AST and ALT decreased. The patient's general condition improved during hospitalization. The RUCAM score was estimated at 8. 4. Conclusions: This case is presented to bring more attention to the toxicity of herbal medicine.

키워드

참고문헌

  1. Dept. of Sasang Constitutional Medicine college of Oriental Medicine, the whole nation. Sasanguihak. Seoul:Jipmoondang. 2004:280-281, 290-294,420-421, 705-713. (Korean)
  2. Chae HB. Clinical features and diagnosis of drug-induced liver injury: single topic symposium. Korean J Hepatol. 2004;10(1):7-16. (Korean)
  3. Schiano TD. Hepatotoxicity and com-plementary and alternative medicines. Clin Liver Dis. 2003;7(2):453-473 https://doi.org/10.1016/S1089-3261(03)00030-8
  4. Pittler MH, Ernst E. Systemic Review:hepatotoxic events associated with herbal medicinal products. Aliment Pharmacol Ther. 2003;18(5):451-471 https://doi.org/10.1046/j.1365-2036.2003.01689.x
  5. Benichou C. Criteria of drug-induced liver disorders. Report of an international Consensus Meeting. J Hepatol.1990;11:272-276 https://doi.org/10.1016/0168-8278(90)90124-A
  6. Danan G. Bénichou C. Causality assessment of adverse reactions to drugs- I .A novel method based on the conclusions of international consensus meetings: applications to drug induced liver injuries. J Clin Epidemiol. 1993;46(11):1323-1330 https://doi.org/10.1016/0895-4356(93)90101-6
  7. Lucena MI. García-cortés M. Cueto R. Lopez-Duran J. Andrade RJ. Assessment of drug-induced liver injuty in clinical practice. Fundam Clin Pharmacil.2008;22(2):141-158 https://doi.org/10.1111/j.1472-8206.2008.00566.x
  8. Ahn BM. Diagnosis and treatment of drug-induced liver injury. Korean J Hepatol. 2001;7(1):45-63. (Korean)
  9. Han KS. Park SS. The study on prescription's combination of Taeumin. J of Sasang Constitutional Medicine. 2007;19(2):1-10. (Korean)
  10. Lee JM. Donguisusebowon. Eulyumunhwasa. 2002. (Korean)
  11. Won JS. Dongui sasang shinpyun. Munusa. 1929. (Korean)
  12. Kim JC, Park HM, Cho HS, Park JH, Lee JE, Song CH, Oh SW, Sun SH. Comparison of liver function test score by herbal medication duration. Korean J.Orienh.int.med. 2005;aut(1):37-45. (Korean)
  13. Lee SH, Lee MS, Song MD. One case of the hepatic injury suggested toxic hepatitis(drug induced hepatitis) in the treatment of oriental medicine for cerebral infarction. Korean J.Orienh.int.med.2000;21(5):869-872. (Korean)
  14. Kim TH, Hong SY, Han DN, Lim EC. The effects of constant use of yeoldahanso-tang on liver function. J of Sasang Constitutional Medicine. 2007;19(3):217-226. (Korean)
  15. Jiabo Wang, Yanling Zhao, Xiaohe Xiao, Huifang Li, Haiping Zhao, Ping Zhang and Cheng Jin. Assessment of the renal protection and hepatotoxicity of rhubarb extract in rats. Journal of Ethnopharmacology. 2009;124(1):18-25 https://doi.org/10.1016/j.jep.2009.04.018
  16. Q.X.Wang, C.Q.Wu, M.Y.Liao. Study on the toxicity of rhubarb and main components contained in it. Journal of Toxicology. 2007;21:301–302
  17. Y.P.Zhou, J.L.Jiang. Review on the pharmacological researches of rhubarb, Pharmacology and Clinics of Chinese Materia Medica. 1991;7:41–43
  18. Y.T. Zhan, H.S. Wei, Z.R. Wang, X. Huang, Q.F. Xu, D.G. Li, H.M. Lu. Effects of emodin on hepatic fibrosis in rats. Chinese Journal of Hepatology. 2001;9:235–239
  19. Yun YJ, Shin BC, Shin WJ, Jang IS. Suggestion of herbal medicine-induced liver injury investigation forms for improving the research quality of herbal safety. Korean J.Orienh.int.med. 2009;30(1):181-190. (Korean)
  20. Pachkoria K, Lucena MI, Molokhia M. Cueto R. Carballo AS, Carvajal A et al. Genetic and molecular factors in drug-induced liver injury:a review. Curr Drug Saf. 2007;2(2):97-112 https://doi.org/10.2174/157488607780598287
  21. Yoo TW, Kim BI, Kim JB, Kim DJ, Kim JW, Baik SK, Kim KS, Cheon GJ. The survey for the actual condition of drug medication and development of health care cost associated with toxic liver injury in Korea; a multicenter study for the detection and the development of nationwide reporting system of toxic liver injury. Korean J Hepatol. 2007;13(1):34-43. (Korean)